Cardiovascular information systems offer an ideal workflow, which allows easy access of information to the staff for complete visibility of a patient's health history. The system offers patient's prior history along with current procedural data/imaging. These information systems enable to view current & historical images and data in multiple locations in real-time, which simplifies virtual cardiac care.
The global market for Cardiovascular Information Systems was estimated to be worth US$ 795.6 million in 2023 and is forecast to a readjusted size of US$ 1217.1 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030
Cardiovascular Information System (CVIS) is an information system specially used to manage and store cardiovascular medical data. It is closely related to clinical work in the field of cardiovascular medicine and aims to provide an integrated platform to facilitate medical institutions to comprehensively manage and coordinate care for cardiovascular patients.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Information Systems, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cardiovascular Information Systems by region & country, by Type, and by Application.
The Cardiovascular Information Systems market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Information Systems.
麻豆原创 Segmentation
By Company
Siemens Healthcare
Cerner Corporation
Fujifilm
General Electric
LUMEDX
McKesson Corporation
Koninklijke Philips
Agfa-Gevaert Group.
Shimadzu Corporation
IBM
Segment by Type:
On-Site CVIS
Web-Based CVIS
Cloud-Based CVIS
Segment by Application
Hospital
Diagnostic Center
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiovascular Information Systems manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cardiovascular Information Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cardiovascular Information Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Cardiovascular Information Systems Product Introduction
1.2 Global Cardiovascular Information Systems 麻豆原创 Size Forecast
1.3 Cardiovascular Information Systems 麻豆原创 Trends & Drivers
1.3.1 Cardiovascular Information Systems Industry Trends
1.3.2 Cardiovascular Information Systems 麻豆原创 Drivers & Opportunity
1.3.3 Cardiovascular Information Systems 麻豆原创 Challenges
1.3.4 Cardiovascular Information Systems 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiovascular Information Systems Players Revenue Ranking (2023)
2.2 Global Cardiovascular Information Systems Revenue by Company (2019-2024)
2.3 Key Companies Cardiovascular Information Systems Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cardiovascular Information Systems Product Offered
2.5 Key Companies Time to Begin Mass Production of Cardiovascular Information Systems
2.6 Cardiovascular Information Systems 麻豆原创 Competitive Analysis
2.6.1 Cardiovascular Information Systems 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cardiovascular Information Systems Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular Information Systems as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 On-Site CVIS
3.1.2 Web-Based CVIS
3.1.3 Cloud-Based CVIS
3.2 Global Cardiovascular Information Systems Sales Value by Type
3.2.1 Global Cardiovascular Information Systems Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cardiovascular Information Systems Sales Value, by Type (2019-2030)
3.2.3 Global Cardiovascular Information Systems Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Diagnostic Center
4.2 Global Cardiovascular Information Systems Sales Value by Application
4.2.1 Global Cardiovascular Information Systems Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cardiovascular Information Systems Sales Value, by Application (2019-2030)
4.2.3 Global Cardiovascular Information Systems Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cardiovascular Information Systems Sales Value by Region
5.1.1 Global Cardiovascular Information Systems Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cardiovascular Information Systems Sales Value by Region (2019-2024)
5.1.3 Global Cardiovascular Information Systems Sales Value by Region (2025-2030)
5.1.4 Global Cardiovascular Information Systems Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cardiovascular Information Systems Sales Value, 2019-2030
5.2.2 North America Cardiovascular Information Systems Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cardiovascular Information Systems Sales Value, 2019-2030
5.3.2 Europe Cardiovascular Information Systems Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cardiovascular Information Systems Sales Value, 2019-2030
5.4.2 Asia Pacific Cardiovascular Information Systems Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cardiovascular Information Systems Sales Value, 2019-2030
5.5.2 South America Cardiovascular Information Systems Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cardiovascular Information Systems Sales Value, 2019-2030
5.6.2 Middle East & Africa Cardiovascular Information Systems Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiovascular Information Systems Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cardiovascular Information Systems Sales Value
6.3 United States
6.3.1 United States Cardiovascular Information Systems Sales Value, 2019-2030
6.3.2 United States Cardiovascular Information Systems Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cardiovascular Information Systems Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cardiovascular Information Systems Sales Value, 2019-2030
6.4.2 Europe Cardiovascular Information Systems Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cardiovascular Information Systems Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cardiovascular Information Systems Sales Value, 2019-2030
6.5.2 China Cardiovascular Information Systems Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cardiovascular Information Systems Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cardiovascular Information Systems Sales Value, 2019-2030
6.6.2 Japan Cardiovascular Information Systems Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cardiovascular Information Systems Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cardiovascular Information Systems Sales Value, 2019-2030
6.7.2 South Korea Cardiovascular Information Systems Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cardiovascular Information Systems Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiovascular Information Systems Sales Value, 2019-2030
6.8.2 Southeast Asia Cardiovascular Information Systems Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cardiovascular Information Systems Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cardiovascular Information Systems Sales Value, 2019-2030
6.9.2 India Cardiovascular Information Systems Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cardiovascular Information Systems Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Siemens Healthcare
7.1.1 Siemens Healthcare Profile
7.1.2 Siemens Healthcare Main Business
7.1.3 Siemens Healthcare Cardiovascular Information Systems Products, Services and Solutions
7.1.4 Siemens Healthcare Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.1.5 Siemens Healthcare Recent Developments
7.2 Cerner Corporation
7.2.1 Cerner Corporation Profile
7.2.2 Cerner Corporation Main Business
7.2.3 Cerner Corporation Cardiovascular Information Systems Products, Services and Solutions
7.2.4 Cerner Corporation Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.2.5 Cerner Corporation Recent Developments
7.3 Fujifilm
7.3.1 Fujifilm Profile
7.3.2 Fujifilm Main Business
7.3.3 Fujifilm Cardiovascular Information Systems Products, Services and Solutions
7.3.4 Fujifilm Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.3.5 General Electric Recent Developments
7.4 General Electric
7.4.1 General Electric Profile
7.4.2 General Electric Main Business
7.4.3 General Electric Cardiovascular Information Systems Products, Services and Solutions
7.4.4 General Electric Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.4.5 General Electric Recent Developments
7.5 LUMEDX
7.5.1 LUMEDX Profile
7.5.2 LUMEDX Main Business
7.5.3 LUMEDX Cardiovascular Information Systems Products, Services and Solutions
7.5.4 LUMEDX Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.5.5 LUMEDX Recent Developments
7.6 McKesson Corporation
7.6.1 McKesson Corporation Profile
7.6.2 McKesson Corporation Main Business
7.6.3 McKesson Corporation Cardiovascular Information Systems Products, Services and Solutions
7.6.4 McKesson Corporation Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.6.5 McKesson Corporation Recent Developments
7.7 Koninklijke Philips
7.7.1 Koninklijke Philips Profile
7.7.2 Koninklijke Philips Main Business
7.7.3 Koninklijke Philips Cardiovascular Information Systems Products, Services and Solutions
7.7.4 Koninklijke Philips Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.7.5 Koninklijke Philips Recent Developments
7.8 Agfa-Gevaert Group.
7.8.1 Agfa-Gevaert Group. Profile
7.8.2 Agfa-Gevaert Group. Main Business
7.8.3 Agfa-Gevaert Group. Cardiovascular Information Systems Products, Services and Solutions
7.8.4 Agfa-Gevaert Group. Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.8.5 Agfa-Gevaert Group. Recent Developments
7.9 Shimadzu Corporation
7.9.1 Shimadzu Corporation Profile
7.9.2 Shimadzu Corporation Main Business
7.9.3 Shimadzu Corporation Cardiovascular Information Systems Products, Services and Solutions
7.9.4 Shimadzu Corporation Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.9.5 Shimadzu Corporation Recent Developments
7.10 IBM
7.10.1 IBM Profile
7.10.2 IBM Main Business
7.10.3 IBM Cardiovascular Information Systems Products, Services and Solutions
7.10.4 IBM Cardiovascular Information Systems Revenue (US$ Million) & (2019-2024)
7.10.5 IBM Recent Developments
8 Industry Chain Analysis
8.1 Cardiovascular Information Systems Industrial Chain
8.2 Cardiovascular Information Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiovascular Information Systems Sales Model
8.5.2 Sales Channel
8.5.3 Cardiovascular Information Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Siemens Healthcare
Cerner Corporation
Fujifilm
General Electric
LUMEDX
McKesson Corporation
Koninklijke Philips
Agfa-Gevaert Group.
Shimadzu Corporation
IBM
听
听
*If Applicable.